Functional Analysis of Bacillus anthracis Protective Antigen by Using Neutralizing Monoclonal Antibodies†

AUTOR(ES)

Brossier, Fabien

FONTE

American Society for Microbiology

RESUMO

Protective antigen (PA) is central to the action of the lethal and edema toxins produced by Bacillus anthracis. It is the common cell-binding component, mediating the translocation of the enzymatic moieties (lethal factor [LF] and edema factor) into the cytoplasm of the host cell. Monoclonal antibodies (MAbs) against PA, able to neutralize the activities of the toxins in vitro and in vivo, were screened. Two such MAbs, named 7.5 and 48.3, were purified and further characterized. MAb 7.5 binds to domain 4 of PA and prevents the binding of PA to its cell receptor. MAb 48.3 binds to domain 2 and blocks the cleavage of PA into PA63, a step necessary for the subsequent interaction with the enzymatic moieties. The epitope recognized by this antibody is in a region involved in the oligomerization of PA63; thus, MAb 48.3 does not recognize the oligomer form. MAbs 7.5 and 48.3 neutralize the activities of anthrax toxins produced by B. anthracis in mice. Also, there is an additive effect between the two MAbs against PA and a MAb against LF, in protecting mice against a lethal challenge by the Sterne strain. This work contributes to the functional analysis of PA and offers immunotherapeutic perspectives for the treatment of anthrax disease.

Documentos Relacionados

• Identification of Linear Epitopes in Bacillus anthracis Protective Antigen Bound by Neutralizing Antibodies*
• Functional Analysis of the Carboxy-Terminal Domain of Bacillus anthracis Protective Antigen
• Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin.
• Babesia bovis: isolation of a protective antigen by using monoclonal antibodies.
• Enzyme-linked immunosorbent assay using a recombinant baculovirus-expressed Bacillus anthracis protective antigen (PA): measurement of human anti-PA antibodies.